# Pfizer Inc. (PFE) — Q3-2017 Earnings Results

**Report date:** 2017-10-31 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/PFE/earnings/Q3-2017

## Post-Earnings Brief

### Headline

Pfizer Beats on EPS, Stock Down 0.26%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.67 | N/A | +1.14% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed a positive outlook on their product pipeline. However, they did not provide specific guidance for the upcoming quarters.

**Key quotes:**

> Management highlighted ongoing developments in their pipeline.

> They emphasized the importance of innovation in driving future growth.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Pfizer's earnings report showed a slight beat on EPS, which may indicate better-than-expected profitability. However, the stock reacted negatively, declining by 0.26%. This could suggest investor concerns about future revenue growth or lack of guidance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/PFE/earnings/Q3-2017_